| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020669 |
| Receipt No. | R000023855 |
| Official scientific title of the study | An open trial regarding the safety and efficacy of blonanserin for patients with gambling disorder |
| Date of disclosure of the study information | 2016/01/21 |
| Last modified on | 2017/04/27 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | An open trial regarding the safety and efficacy of blonanserin for patients with gambling disorder | |
| Title of the study (Brief title) | Open trial of blonanserin for gambling disorder | |
| Region |
|
|
| Condition | ||
| Condition | Gambling disorder | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the safety and efficacy of blonanserin for patients with gambling disorder |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Overall severity of DIEPSS at 8 weeks |
| Key secondary outcomes | The change of the scores in GSAS, PG-YBOCS, BIS-11, and CGI-C at 8 weeks |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Blonanserin, 2-12 mg/day, 8 weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Gambling disorder as defined by DSM-5
2. Outpatients of Chiba University Hospital 3. 20<= age at consent < 65 4. 5>= SOGS score |
|||
| Key exclusion criteria | 1. Incompetent
2. Pregnant, nursing, or being expected as so 3. F2 or F0 by ICD-10 4. uncontrolled physical illness 5. taking antipsychotic drugs within 28 days before 6. taking prohibited with blonanserin 7. history of allergic reaction for blonanserin 8. history of malignant syndrome or tardive dyskinesia caused by antipsychotic drugs 9. participated other clinical trials within 3 month before 10. 15 >= MADRS 11. 15 >= YMRS 12. 3 >= overall severity of DIEPSS 13. history of suicide attempt within one years before 14. contraindicated by the doctor in charge |
|||
| Target sample size | 3 | |||
| Research contact person | |
| Name of lead principal investigator | Akihiro Shiina |
| Organization | Chiba University |
| Division name | Department of psychiatry, Graduate school of medicine |
| Address | Inohana 1-8-1, Chuoh-ku, Chiba-shi |
| TEL | +81-42-222-7171 |
| shiina-akihiro@faculty.chiba-u.jp | |
| Public contact | |
| Name of contact person | Akihiro Shiina |
| Organization | Chiba University |
| Division name | Department of psychiatry, Graduate school of medicine |
| Address | Inohana 1-8-1, Chuoh-ku, Chiba-shi |
| TEL | +81-42-222-7171 |
| Homepage URL | |
| shiina-akihiro@faculty.chiba-u.jp | |
| Sponsor | |
| Institute | Chiba University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Council for Addiction Behavior Studies |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | G27039 |
| Org. issuing International ID_1 | Chiba University Hospital Clinical Research Center |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 千葉大学医学部附属病院(千葉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023855 |